Education
About Us
Working with TipRanks
Follow Us
Mizuho Medy Co., Ltd. (JP:4595)
:4595
4595 Stock Chart & Stats
¥1753.00
¥40.00(2.73%)
At close: 4:00 PM EST
¥1753.00
¥40.00(2.73%)
Day’s Range― - ―
52-Week Range¥1,341.00 - ¥1,777.00
Previous CloseN/A
Volume223.50K
Average Volume (3M)64.11K
Market Cap
¥33.76B
Enterprise Value¥20.02B
Total Cash (Recent Filing)¥12.37B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)12.0
Beta0.39
Next Earnings
Feb 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield6.29%
Share Statistics
EPS (TTM)29.82
Shares Outstanding19,051,200
10 Day Avg. Volume72,640
30 Day Avg. Volume64,113
Financial Highlights & Ratios
PEG Ratio-250.24
Price to Book (P/B)1.65
Price to Sales (P/S)2.50
P/FCF Ratio9.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
4595 FAQ
What was Mizuho Medy Co., Ltd.’s price range in the past 12 months?
Mizuho Medy Co., Ltd. lowest stock price was ¥1341.00 and its highest was ¥1777.00 in the past 12 months.
What is Mizuho Medy Co., Ltd.’s market cap?
Mizuho Medy Co., Ltd.’s market cap is ¥33.76B.
When is Mizuho Medy Co., Ltd.’s upcoming earnings report date?
Mizuho Medy Co., Ltd.’s upcoming earnings report date is Feb 13, 2026 which is in 31 days.
How were Mizuho Medy Co., Ltd.’s earnings last quarter?
Mizuho Medy Co., Ltd. released its earnings results on Nov 07, 2025. The company reported ¥29.82 earnings per share for the quarter, beating the consensus estimate of N/A by ¥29.82.
Is Mizuho Medy Co., Ltd. overvalued?
According to Wall Street analysts Mizuho Medy Co., Ltd.’s price is currently Overvalued.
Does Mizuho Medy Co., Ltd. pay dividends?
Mizuho Medy Co., Ltd. pays a Semiannually dividend of ¥45 which represents an annual dividend yield of 6.29%. See more information on Mizuho Medy Co., Ltd. dividends here
What is Mizuho Medy Co., Ltd.’s EPS estimate?
Mizuho Medy Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mizuho Medy Co., Ltd. have?
Mizuho Medy Co., Ltd. has 19,051,200 shares outstanding.
What happened to Mizuho Medy Co., Ltd.’s price movement after its last earnings report?
Mizuho Medy Co., Ltd. reported an EPS of ¥29.82 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.312%.
Which hedge fund is a major shareholder of Mizuho Medy Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4595
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mizuho Medy Co., Ltd.
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits. It also offers gene analysis instrument; SARS-CoV-2 detection kits; and mycoplasma pneumoniae nucleic acid kits. In addition, the company engages in import and export activities. It also operates in the United States, Belgium, Finland, Netherlands, Taiwan, Thailand, etc. The company was incorporated in 1977 and is headquartered in Tosu, Japan.
Technical Analysis
Fuji Pharma Co., Ltd.
―
Fuso Pharmaceutical Industries,Ltd.
―
KYORIN Pharmaceutical Co.,Ltd.
―
Daito Pharmaceutical Co., Ltd.
―
ASKA Pharmaceutical Holdings Co., Ltd.
―
Options Prices
Currently, No data available
---